![]() Radius Health Radius is a biopharmaceutical company developing new therapeutics for patients with osteoporosis and other serious endocrine-mediated diseases. | ![]() Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 2003 | Founding Date 1904 | Founding Date 1976 | Founding Date 1928 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Boston, US HQ Wayne, US | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 3834% decrease | Employees 7,5692% decrease | Employees 18,077 | Employees 9,052 |
Valuation ($) | Valuation ($) 480.6 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 34.3 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $230m (FY, 2021) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) N/A | Revenue (est.) €7.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $4.5b (FY, 2020) | Gross profit N/A | Gross profit €7.2b (FY, 2025) |
Net income | Net income ($70.2m) (FY, 2021) | Net income N/A | Net income N/A | Net income €1.6b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries N/A | Countries 100 (Dec, 2020) | Countries N/A | Countries 35 (FY, 2019) |

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company